Medical/Pharmaceuticals APAC News & Press Release Distribution

BioVaxys Further Expands Intellectual Property Portfolio in Global Markets

- Files Applications for International Patent and Trademark Protection of CoviDTH VANCOUVER, BC, Oct. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV), (FRA: 5LB), (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that it has broadened the patent coverage on CoviDTH, its T ...

2021-10-28 20:00 3951

Interim report for Q3 2021 : Bactiguard Holding AB (publ)

STOCKHOLM, Oct. 28, 2021 /PRNewswire/ -- Capital injection initiates a new phase of accelerated expansion Third quarter (July-September 2021) * Revenues amounted to SEK 45.2 (34.1) million, an increase of 32%. Adjusted for currency effects revenues increased by 36%. * EBITDA amounted to SEK ...

2021-10-28 15:23 2359

Mentice publishes the company's interim report for the period January-September 2021

STOCKHOLM, Oct. 28, 2021 /PRNewswire/ -- Third quarter (July–September 2021) and the first nine months of the year (January-September 2021) * Order intake amounted to 51.8 (34.6) MSEK for the third quarter and 131.9 (95.5) MSEK for the first nine months of the year. * Order book by the end ...

2021-10-28 15:07 1997

Innovent and NeoCura Announce Strategic Collaboration to Study the Combination Therapy of Sintilimab and Neoantigen Vaccine NEO_PLIN2101 for Cancer Treatment in China

SAN FRANCISCO and SUZHOU, China, Oct. 28, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-10-28 08:00 4034

Ingersoll Rand and its Brands Support the Public Health in the Post-Pandemic Era

SINGAPORE, Oct. 27, 2021 /PRNewswire/ -- Ingersoll Rand Inc. (NYSE:IR), a global provider of mission-critical flow creation and industrial solutions, is providing compressed air and vacuum, material handling, and metering solutions to the medical and pharmaceutical industries. Its cutting-edge co...

2021-10-28 05:47 4172

Ingersoll Rand and its Brands Support the Public Health in the Post-Pandemic Era

New Wellbeing Trends Report 2030 Reveals Decade-long Impact of Pandemic Upheaval

SYDNEYOct. 28, 2021 /PRNewswire/ -- Jeunesse Global today shared the inaugural Wellness & Aesthetics Trends Report 2030, presenting key macro and micro trends that are set to influence the future of the wellbeing and beauty sectors, based on the evolution of audience behaviours and cultural shift...

2021-10-28 03:54 2703

Launch of Seegene's STARlet-AIOS: All-in-One System Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing

* A true walk away 'sample to answer' molecular diagnostic system designed for high throughput testing, offering a time-efficient and seamless workflow for clinical laboratories * Utilizes Seegene's patented, cutting-edge high multiplex real-time PCR technologies to provide 'Real' Ct values...

2021-10-27 23:40 2930

Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients

LONDON, Oct. 27, 2021 /PRNewswire/ -- Frontier Biotechnologies today shared real-world evidence of Albuvirtide (ABT)-based two drug regimen's safety and efficacy for hospitalized AIDS patients at the European AIDS Clinical Society (EACS) Conference. Observations from a single-center, retrospec...

2021-10-27 22:08 2012

Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients

LONDON, Oct. 27, 2021 /PRNewswire/ -- Frontier Biotechnologies today shared real-world evidence of Albuvirtide (ABT)-based two drug regimen's safety and efficacy for hospitalized AIDS patients at the European AIDS Clinical Society (EACS) Conference. Observations from a single-center, retrospec...

2021-10-27 22:06 1745

Frontier Biotechnologies' Long-acting Injectable (Aikening(R)), In A Two Drug Regimen, Proves Safe And Effective For Critically Ill Hospitalized AIDS Patients

LONDON, Oct. 27, 2021 /PRNewswire/ -- Frontier Biotechnologies today shared real-world evidence of Albuvirtide (ABT)-based two drug regimen's safety and efficacy for hospitalized AIDS patients at the European AIDS Clinical Society (EACS) Conference. Observations from a single-center, retrospec...

2021-10-27 22:03 1899

Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore

- Phase 1b/2 trial to be conducted at the National University Cancer Institute, Singapore and the National Cancer Centre Singapore, in Collaboration with the Singapore Translational Cancer Consortium - - ADG106 now being evaluated in combinations with three leading anti-PD-1 therapies - SAN DIEG...

2021-10-27 20:52 4643

Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore

Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom

* Filing marks first protein-based COVID-19 vaccine submitted to MHRA for authorization * All modules required for regulatory review, including CMC data, are now complete * Submission based on Phase 3 data from ~45K patients demonstrating high efficacy and well-tolerated safety, including a...

2021-10-27 20:30 4104

European Wellness Collaborates with Heidelberg University Germany to Conduct Efficacy Studies of Peptides and Cell Therapy Research

FRANKFURT, Germany, Oct. 27, 2021 /PRNewswire/ – European Wellness Academy (EWA), the educational arm of European Wellness Biomedical Group (EWG), has signed an agreement to carry out joint scientific research on theefficacy of peptides, cell therapy, exosomes and cell reprogramming for rejuvenat...

2021-10-27 18:48 3629

Launch of #SGUnited COVID-19 Assistance Telemedicine Initiative by UNO Tech

SINGAPORE, Oct. 27, 2021 /PRNewswire/ -- Singapore has seen a sharp increase in daily COVID-19 cases since September, reaching an approximate average of 3,000 daily cases. Primary Care avenues such as General Practitioners and Telemedicine service providers are stretched thin.

2021-10-27 15:04 2469

Launch of #SGUnited COVID-19 Assistance Telemedicine Initiative by UNO Tech

HT Supreme® Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication

TIANJIN, China, Oct. 27, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, announced that the clinical trial results for its HT Supreme® Drug-Eluting Stent (DES) System has been published in Circulation. The article described results from the PIONEER III trial where i...

2021-10-27 15:00 3594

Haier's HCH Ventures Partners with RF Imaging Leader Vayyar to Establish Joint Venture in China

The Joint Venture partnership will initially focus on providing touchless fall detection for seniors as well as expanding Vayyar's activities in the Chinese market - HCH, a subsidiary of Haier, signs Joint Venture agreement with Israeli technology provider, Vayyar, aiming to address the4 trillio...

2021-10-27 14:00 4555

Haier's HCH Ventures Partners with RF Imaging Leader Vayyar to Establish Joint Venture in China

Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity Trial Vaccines

TAIPEI, Oct. 27, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World Health Organisation (WHO) Solidarity Trial Vacci...

2021-10-27 10:24 4698

Elekta receives initial investment grade rating from S&P Global Ratings

STOCKHOLM, Oct. 26, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has received an investment grade (IG) rating from S&P Global Ratings (S&P). S&P has assigned a BBB- rating to Elekta and to the Group's senior unsecured notes, with stable outlook. S&P notes that Elekta's rating r...

2021-10-26 20:50 2456

Introducing Prodigy for Improved Peptide Purification

-- Improved resolution and separation of peptide impurities -- Easier purification of hydrophobic peptides -- Direct transfer from analytical to preparative scale MATTHEWS, N.C., Oct. 26, 2021 /PRNewswire/ -- CEM Corporation is proud to announce the release of the new Prodigy™ Preparative High-P...

2021-10-26 20:28 4750

Introducing Prodigy for Improved Peptide Purification

Medigate Launches Clinical Device Efficiency to Improve Operational Efficiency for HDOs

The new offering from the medical device cybersecurity leader aims to increase medical device visibility, streamline hospital workflows, and reduce costs BROOKLYN, N.Y., Oct. 26, 2021 /PRNewswire/ -- Medigate, creator of the industry's first and leading healthcare-specific platform to orchestrate...

2021-10-26 20:00 2052